| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Corpus Luteum | 21 | 2010 | 86 | 3.110 |
Why?
|
| Ovarian Neoplasms | 31 | 2024 | 4839 | 2.580 |
Why?
|
| Neoplastic Stem Cells | 12 | 2018 | 1376 | 2.110 |
Why?
|
| Endometrial Neoplasms | 17 | 2017 | 1351 | 1.840 |
Why?
|
| Cyclins | 12 | 2019 | 603 | 1.440 |
Why?
|
| Uterine Neoplasms | 11 | 2018 | 1513 | 1.190 |
Why?
|
| Leiomyoma | 6 | 2018 | 730 | 1.000 |
Why?
|
| Carcinoma, Endometrioid | 4 | 2017 | 271 | 0.980 |
Why?
|
| Dinoprost | 11 | 2010 | 138 | 0.870 |
Why?
|
| Oogenesis | 3 | 2014 | 131 | 0.860 |
Why?
|
| Phosphoproteins | 13 | 2015 | 2441 | 0.860 |
Why?
|
| CA-125 Antigen | 6 | 2024 | 286 | 0.850 |
Why?
|
| Luteolysis | 4 | 2008 | 11 | 0.830 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 2 | 2024 | 140 | 0.790 |
Why?
|
| Genital Neoplasms, Female | 2 | 2024 | 523 | 0.710 |
Why?
|
| Proto-Oncogene Proteins c-kit | 4 | 2018 | 776 | 0.660 |
Why?
|
| Signal Transduction | 30 | 2019 | 23404 | 0.650 |
Why?
|
| Ovary | 7 | 2019 | 981 | 0.630 |
Why?
|
| Carrier Proteins | 12 | 2015 | 5023 | 0.620 |
Why?
|
| Apoptosis | 18 | 2020 | 9724 | 0.620 |
Why?
|
| Progesterone | 12 | 2008 | 775 | 0.600 |
Why?
|
| Oocytes | 6 | 2012 | 1188 | 0.590 |
Why?
|
| Cell Proliferation | 21 | 2023 | 10483 | 0.590 |
Why?
|
| TOR Serine-Threonine Kinases | 6 | 2017 | 2110 | 0.590 |
Why?
|
| Xenograft Model Antitumor Assays | 12 | 2021 | 3554 | 0.560 |
Why?
|
| Carcinosarcoma | 2 | 2014 | 108 | 0.540 |
Why?
|
| Endometriosis | 4 | 2014 | 839 | 0.520 |
Why?
|
| Loss of Heterozygosity | 3 | 2007 | 684 | 0.520 |
Why?
|
| Caspases | 4 | 2003 | 928 | 0.510 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 2 | 2014 | 198 | 0.500 |
Why?
|
| Leptin | 6 | 2009 | 1600 | 0.490 |
Why?
|
| Vitrification | 1 | 2014 | 56 | 0.480 |
Why?
|
| Carboplatin | 3 | 2014 | 801 | 0.480 |
Why?
|
| Receptor, erbB-2 | 6 | 2020 | 2417 | 0.480 |
Why?
|
| Endometrium | 8 | 2017 | 424 | 0.470 |
Why?
|
| Dendritic Cells | 4 | 2014 | 2725 | 0.470 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2017 | 693 | 0.460 |
Why?
|
| Mucin-1 | 1 | 2018 | 543 | 0.460 |
Why?
|
| Cystadenocarcinoma, Serous | 6 | 2020 | 450 | 0.460 |
Why?
|
| DNA Repair | 2 | 2024 | 2046 | 0.460 |
Why?
|
| Ovarian Follicle | 3 | 2019 | 248 | 0.450 |
Why?
|
| Gene Expression Regulation, Neoplastic | 15 | 2020 | 8432 | 0.440 |
Why?
|
| Membrane Proteins | 6 | 2024 | 7882 | 0.440 |
Why?
|
| Mice | 55 | 2023 | 81201 | 0.440 |
Why?
|
| Glycoproteins | 6 | 2013 | 2266 | 0.430 |
Why?
|
| Female | 122 | 2024 | 380193 | 0.430 |
Why?
|
| Animals | 87 | 2023 | 168768 | 0.430 |
Why?
|
| Cryopreservation | 2 | 2014 | 670 | 0.410 |
Why?
|
| Toll-Like Receptors | 2 | 2013 | 593 | 0.410 |
Why?
|
| Cell Line, Tumor | 25 | 2021 | 16690 | 0.410 |
Why?
|
| Teratoma | 1 | 2014 | 395 | 0.400 |
Why?
|
| Oligopeptides | 1 | 2017 | 1189 | 0.390 |
Why?
|
| Receptors, Progesterone | 6 | 2016 | 1098 | 0.390 |
Why?
|
| Mice, SCID | 12 | 2020 | 2716 | 0.380 |
Why?
|
| Keratin-18 | 1 | 2010 | 39 | 0.380 |
Why?
|
| Morpholines | 2 | 2014 | 571 | 0.380 |
Why?
|
| Disease Models, Animal | 10 | 2019 | 18034 | 0.380 |
Why?
|
| Paclitaxel | 4 | 2015 | 1708 | 0.370 |
Why?
|
| Sphingomyelin Phosphodiesterase | 2 | 2008 | 91 | 0.360 |
Why?
|
| Aminopyridines | 1 | 2014 | 542 | 0.360 |
Why?
|
| Uterine Cervical Neoplasms | 4 | 2022 | 2020 | 0.360 |
Why?
|
| Receptors, Notch | 1 | 2014 | 739 | 0.350 |
Why?
|
| Peptides | 7 | 2022 | 4410 | 0.350 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2022 | 2943 | 0.340 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 896 | 0.340 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2015 | 1222 | 0.340 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2013 | 4424 | 0.330 |
Why?
|
| Antigens, CD | 5 | 2013 | 4026 | 0.330 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2014 | 2504 | 0.330 |
Why?
|
| Carcinoma | 3 | 2023 | 2375 | 0.330 |
Why?
|
| Gene Amplification | 6 | 2020 | 1063 | 0.320 |
Why?
|
| Granulosa Cells | 5 | 2019 | 121 | 0.310 |
Why?
|
| Genes, erbB-1 | 1 | 2008 | 161 | 0.310 |
Why?
|
| Immunohistochemistry | 14 | 2017 | 11366 | 0.300 |
Why?
|
| Epithelial Cells | 3 | 2019 | 3690 | 0.290 |
Why?
|
| Ovarian Diseases | 1 | 2008 | 139 | 0.290 |
Why?
|
| Hedgehog Proteins | 1 | 2011 | 783 | 0.290 |
Why?
|
| Antineoplastic Agents | 10 | 2023 | 13693 | 0.280 |
Why?
|
| Growth Inhibitors | 1 | 2007 | 385 | 0.270 |
Why?
|
| Mice, Inbred NOD | 9 | 2016 | 1879 | 0.270 |
Why?
|
| Cell Cycle | 5 | 2016 | 2967 | 0.270 |
Why?
|
| Cattle | 14 | 2010 | 3922 | 0.270 |
Why?
|
| Vulvar Neoplasms | 1 | 2008 | 272 | 0.270 |
Why?
|
| RNA, Messenger | 12 | 2014 | 13035 | 0.260 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 2219 | 0.260 |
Why?
|
| Indoles | 4 | 2016 | 1839 | 0.260 |
Why?
|
| Neoplasm, Residual | 1 | 2010 | 973 | 0.260 |
Why?
|
| Epigenomics | 1 | 2010 | 903 | 0.260 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2006 | 137 | 0.260 |
Why?
|
| Cytokines | 6 | 2014 | 7323 | 0.250 |
Why?
|
| Neoplasm Transplantation | 6 | 2013 | 2086 | 0.250 |
Why?
|
| Paraffin Embedding | 2 | 2017 | 299 | 0.250 |
Why?
|
| Humans | 96 | 2024 | 744366 | 0.250 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2008 | 547 | 0.240 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2016 | 11525 | 0.240 |
Why?
|
| Gene Silencing | 2 | 2007 | 1539 | 0.240 |
Why?
|
| Adenocarcinoma, Clear Cell | 2 | 2005 | 221 | 0.240 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2024 | 363 | 0.230 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2007 | 671 | 0.230 |
Why?
|
| Repressor Proteins | 3 | 2022 | 3024 | 0.230 |
Why?
|
| I-kappa B Proteins | 2 | 2001 | 225 | 0.230 |
Why?
|
| Stem Cells | 4 | 2011 | 3567 | 0.220 |
Why?
|
| Microsatellite Repeats | 2 | 2006 | 802 | 0.220 |
Why?
|
| Caspase 3 | 5 | 2010 | 758 | 0.220 |
Why?
|
| Pre-Eclampsia | 1 | 2012 | 1200 | 0.210 |
Why?
|
| MicroRNAs | 5 | 2018 | 3751 | 0.210 |
Why?
|
| Carcinoma in Situ | 1 | 2008 | 806 | 0.210 |
Why?
|
| Sphingomyelins | 1 | 2002 | 106 | 0.210 |
Why?
|
| Neovascularization, Pathologic | 5 | 2014 | 2638 | 0.210 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2018 | 5172 | 0.210 |
Why?
|
| Fas Ligand Protein | 4 | 2010 | 216 | 0.210 |
Why?
|
| Tumor Cells, Cultured | 9 | 2020 | 6313 | 0.210 |
Why?
|
| Pyrroles | 3 | 2013 | 1146 | 0.210 |
Why?
|
| Fatty Acids, Omega-3 | 3 | 2018 | 1344 | 0.200 |
Why?
|
| Papillomaviridae | 3 | 2022 | 1119 | 0.190 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2016 | 2938 | 0.190 |
Why?
|
| Uterus | 5 | 2014 | 711 | 0.190 |
Why?
|
| Tissue Adhesions | 2 | 2012 | 235 | 0.190 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2022 | 2850 | 0.190 |
Why?
|
| Glutamine | 1 | 2023 | 579 | 0.190 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2022 | 362 | 0.190 |
Why?
|
| Cytomegalovirus Infections | 2 | 2022 | 820 | 0.180 |
Why?
|
| Transcription Factors | 7 | 2019 | 12207 | 0.180 |
Why?
|
| Steroids | 2 | 2002 | 930 | 0.180 |
Why?
|
| Myometrium | 2 | 2018 | 181 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 14 | 2019 | 21833 | 0.170 |
Why?
|
| Adenocarcinoma | 6 | 2014 | 6364 | 0.170 |
Why?
|
| Ceramides | 3 | 2008 | 199 | 0.170 |
Why?
|
| MAP Kinase Signaling System | 3 | 2003 | 1525 | 0.170 |
Why?
|
| Alphapapillomavirus | 1 | 2022 | 221 | 0.170 |
Why?
|
| Neoadjuvant Therapy | 1 | 2010 | 2727 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2002 | 1284 | 0.170 |
Why?
|
| Enzyme Precursors | 1 | 1999 | 176 | 0.170 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2013 | 4554 | 0.170 |
Why?
|
| Reactive Oxygen Species | 2 | 2023 | 2076 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 18 | 3 | 2007 | 245 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 5 | 2017 | 5534 | 0.160 |
Why?
|
| Receptors, Prostaglandin | 5 | 2005 | 57 | 0.160 |
Why?
|
| Cell Count | 3 | 2014 | 1856 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 2917 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2014 | 3511 | 0.160 |
Why?
|
| Receptors, Cell Surface | 3 | 2006 | 2865 | 0.160 |
Why?
|
| Galectins | 1 | 2021 | 268 | 0.160 |
Why?
|
| Interferon-gamma | 4 | 2008 | 3207 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2024 | 3873 | 0.150 |
Why?
|
| Gene Expression | 5 | 2015 | 7798 | 0.150 |
Why?
|
| Reproduction | 2 | 2012 | 668 | 0.150 |
Why?
|
| Membrane Glycoproteins | 3 | 2003 | 3771 | 0.150 |
Why?
|
| Endothelium, Vascular | 3 | 2008 | 4459 | 0.150 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2018 | 307 | 0.150 |
Why?
|
| Clone Cells | 1 | 2020 | 1692 | 0.150 |
Why?
|
| ras Proteins | 2 | 2013 | 1060 | 0.140 |
Why?
|
| RNA, Small Interfering | 5 | 2019 | 3505 | 0.140 |
Why?
|
| Mice, Knockout | 9 | 2019 | 14561 | 0.140 |
Why?
|
| Celiac Disease | 1 | 2004 | 785 | 0.140 |
Why?
|
| Feedback, Physiological | 1 | 2019 | 479 | 0.140 |
Why?
|
| Tumor Burden | 4 | 2016 | 1915 | 0.140 |
Why?
|
| Endometrial Hyperplasia | 1 | 2017 | 97 | 0.140 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2009 | 4034 | 0.140 |
Why?
|
| Mice, Nude | 7 | 2021 | 3689 | 0.140 |
Why?
|
| Blood Proteins | 1 | 2021 | 1124 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 1115 | 0.130 |
Why?
|
| Cells, Cultured | 12 | 2019 | 19233 | 0.130 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2015 | 2649 | 0.130 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2015 | 730 | 0.130 |
Why?
|
| Cystadenoma, Serous | 1 | 2016 | 102 | 0.130 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 3 | 2016 | 890 | 0.130 |
Why?
|
| Mediator Complex | 1 | 2015 | 109 | 0.130 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2011 | 9240 | 0.130 |
Why?
|
| GPI-Linked Proteins | 1 | 2016 | 435 | 0.130 |
Why?
|
| Serpins | 1 | 1997 | 247 | 0.130 |
Why?
|
| Palliative Care | 1 | 2010 | 3493 | 0.130 |
Why?
|
| Papillomavirus Infections | 2 | 2022 | 1587 | 0.130 |
Why?
|
| Stromal Cells | 2 | 2011 | 1355 | 0.130 |
Why?
|
| Cleavage Stage, Ovum | 1 | 2014 | 44 | 0.120 |
Why?
|
| Gene Expression Profiling | 6 | 2015 | 9445 | 0.120 |
Why?
|
| Immunoconjugates | 1 | 2022 | 901 | 0.120 |
Why?
|
| Cyclic S-Oxides | 1 | 2014 | 21 | 0.120 |
Why?
|
| Cell Communication | 2 | 2020 | 1621 | 0.120 |
Why?
|
| Blotting, Western | 7 | 2014 | 5181 | 0.120 |
Why?
|
| Mice, Transgenic | 5 | 2019 | 9735 | 0.120 |
Why?
|
| Thiadiazoles | 1 | 2014 | 55 | 0.120 |
Why?
|
| Organ Specificity | 1 | 2019 | 2008 | 0.120 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2015 | 648 | 0.120 |
Why?
|
| DNA Methylation | 4 | 2015 | 4285 | 0.120 |
Why?
|
| Adrenomedullin | 1 | 2013 | 87 | 0.120 |
Why?
|
| RNA, Neoplasm | 2 | 2014 | 769 | 0.110 |
Why?
|
| Extracellular Space | 1 | 2015 | 595 | 0.110 |
Why?
|
| Pregnancy | 12 | 2018 | 29144 | 0.110 |
Why?
|
| Hydroxamic Acids | 1 | 2016 | 494 | 0.110 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2013 | 90 | 0.110 |
Why?
|
| Microsatellite Instability | 1 | 2017 | 684 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 2 | 2017 | 6386 | 0.110 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 4328 | 0.110 |
Why?
|
| Pituitary ACTH Hypersecretion | 1 | 2015 | 175 | 0.110 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2018 | 482 | 0.110 |
Why?
|
| Chemokine CCL2 | 3 | 2008 | 619 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2014 | 130 | 0.110 |
Why?
|
| Viral Proteins | 2 | 2019 | 1900 | 0.110 |
Why?
|
| Menarche | 1 | 2015 | 516 | 0.110 |
Why?
|
| Pituitary Gland | 1 | 2015 | 665 | 0.110 |
Why?
|
| DNA | 5 | 2024 | 7294 | 0.110 |
Why?
|
| Transplantation, Heterologous | 3 | 2011 | 2383 | 0.110 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2015 | 375 | 0.110 |
Why?
|
| Neoplasm Staging | 6 | 2017 | 11031 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 323 | 0.110 |
Why?
|
| Capillaries | 2 | 2008 | 773 | 0.110 |
Why?
|
| Genes, MDR | 1 | 2012 | 37 | 0.110 |
Why?
|
| Parity | 1 | 2015 | 929 | 0.110 |
Why?
|
| Meiosis | 1 | 2014 | 339 | 0.110 |
Why?
|
| Allosteric Site | 1 | 2012 | 103 | 0.110 |
Why?
|
| Veratrum Alkaloids | 1 | 2011 | 25 | 0.110 |
Why?
|
| Antigens, Ly | 1 | 2013 | 291 | 0.100 |
Why?
|
| Sirolimus | 2 | 2017 | 1565 | 0.100 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2017 | 1142 | 0.100 |
Why?
|
| Cell Lineage | 2 | 2019 | 2504 | 0.100 |
Why?
|
| Azacitidine | 2 | 2010 | 347 | 0.100 |
Why?
|
| Cytomegalovirus | 2 | 2022 | 733 | 0.100 |
Why?
|
| Genetic Fitness | 1 | 2012 | 121 | 0.100 |
Why?
|
| Blastocyst | 1 | 2014 | 424 | 0.100 |
Why?
|
| Gene Expression Regulation | 5 | 2015 | 12073 | 0.100 |
Why?
|
| Breast Neoplasms | 2 | 2017 | 20824 | 0.100 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2016 | 789 | 0.100 |
Why?
|
| Nucleosomes | 1 | 1995 | 494 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2013 | 3921 | 0.100 |
Why?
|
| Follicular Atresia | 2 | 2008 | 8 | 0.100 |
Why?
|
| Sheep | 4 | 1999 | 1437 | 0.100 |
Why?
|
| Receptor, Notch1 | 1 | 2014 | 502 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 4 | 2019 | 5867 | 0.100 |
Why?
|
| Interleukin-6 | 3 | 2013 | 3203 | 0.100 |
Why?
|
| BRCA1 Protein | 2 | 2024 | 1149 | 0.090 |
Why?
|
| beta Catenin | 3 | 2013 | 1059 | 0.090 |
Why?
|
| Theca Cells | 2 | 2008 | 15 | 0.090 |
Why?
|
| Intestinal Neoplasms | 1 | 2013 | 319 | 0.090 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2012 | 215 | 0.090 |
Why?
|
| Enzyme Activation | 4 | 2010 | 3702 | 0.090 |
Why?
|
| Blotting, Northern | 4 | 2007 | 1581 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2014 | 4751 | 0.090 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 1741 | 0.090 |
Why?
|
| Progestins | 1 | 2012 | 306 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 3 | 2021 | 2725 | 0.090 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2014 | 584 | 0.090 |
Why?
|
| Receptors, Leptin | 3 | 2006 | 361 | 0.090 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2010 | 104 | 0.090 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 4851 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1997 | 1434 | 0.090 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2016 | 1375 | 0.090 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 713 | 0.090 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 354 | 0.090 |
Why?
|
| Mucin-4 | 1 | 2009 | 37 | 0.090 |
Why?
|
| Mutation | 4 | 2014 | 29786 | 0.080 |
Why?
|
| Fertilization in Vitro | 2 | 2014 | 1284 | 0.080 |
Why?
|
| Cell Cycle Proteins | 2 | 2019 | 3464 | 0.080 |
Why?
|
| Cryoprotective Agents | 1 | 2009 | 112 | 0.080 |
Why?
|
| DNA Copy Number Variations | 2 | 2020 | 1941 | 0.080 |
Why?
|
| Homeostasis | 2 | 2019 | 3339 | 0.080 |
Why?
|
| Ganciclovir | 1 | 2009 | 258 | 0.080 |
Why?
|
| Cell Survival | 5 | 2016 | 5882 | 0.080 |
Why?
|
| Cell Separation | 2 | 2020 | 1751 | 0.080 |
Why?
|
| Cisplatin | 2 | 2015 | 1662 | 0.080 |
Why?
|
| Pancreas Transplantation | 1 | 2009 | 187 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2013 | 1097 | 0.080 |
Why?
|
| Luteal Cells | 3 | 2007 | 19 | 0.080 |
Why?
|
| Organ Culture Techniques | 2 | 2019 | 813 | 0.080 |
Why?
|
| Models, Biological | 4 | 2020 | 9584 | 0.080 |
Why?
|
| Immunomodulation | 1 | 2012 | 541 | 0.080 |
Why?
|
| Scleroderma, Systemic | 1 | 2012 | 323 | 0.080 |
Why?
|
| Estrous Cycle | 1 | 2008 | 73 | 0.080 |
Why?
|
| Endothelial Cells | 3 | 2008 | 3486 | 0.080 |
Why?
|
| Genes, ras | 1 | 2010 | 690 | 0.080 |
Why?
|
| Trans-Activators | 3 | 2010 | 2926 | 0.080 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2010 | 2016 | 0.080 |
Why?
|
| Cell Death | 2 | 2010 | 1707 | 0.080 |
Why?
|
| Immunity, Cellular | 1 | 2014 | 1607 | 0.080 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2009 | 627 | 0.080 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2007 | 138 | 0.080 |
Why?
|
| Oncogenes | 1 | 2013 | 1265 | 0.080 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2008 | 262 | 0.070 |
Why?
|
| Pregnancy, Animal | 1 | 2008 | 134 | 0.070 |
Why?
|
| Nervous System | 1 | 2010 | 554 | 0.070 |
Why?
|
| Embryo, Nonmammalian | 1 | 2010 | 895 | 0.070 |
Why?
|
| DNA, Complementary | 3 | 2003 | 2050 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2008 | 264 | 0.070 |
Why?
|
| Cell Differentiation | 4 | 2019 | 11486 | 0.070 |
Why?
|
| Postpartum Period | 1 | 2013 | 1086 | 0.070 |
Why?
|
| Germ Cells | 2 | 2010 | 631 | 0.070 |
Why?
|
| DNA Fragmentation | 3 | 2002 | 242 | 0.070 |
Why?
|
| Homeodomain Proteins | 2 | 2014 | 2418 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2019 | 3390 | 0.070 |
Why?
|
| Receptors, Cytokine | 2 | 2004 | 262 | 0.070 |
Why?
|
| Ovum | 1 | 2007 | 189 | 0.070 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2011 | 571 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 2015 | 2108 | 0.070 |
Why?
|
| Interferon Regulatory Factor-1 | 2 | 2008 | 68 | 0.070 |
Why?
|
| Mesoderm | 1 | 2009 | 686 | 0.070 |
Why?
|
| Genes, MHC Class I | 1 | 2006 | 258 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2008 | 595 | 0.070 |
Why?
|
| Zebrafish | 2 | 2022 | 2996 | 0.070 |
Why?
|
| Protein Isoforms | 2 | 2010 | 1730 | 0.070 |
Why?
|
| Models, Animal | 1 | 2012 | 2173 | 0.070 |
Why?
|
| Genetic Markers | 1 | 2012 | 2634 | 0.060 |
Why?
|
| Colon | 1 | 2013 | 1772 | 0.060 |
Why?
|
| Colonic Neoplasms | 2 | 2009 | 2542 | 0.060 |
Why?
|
| Phenotype | 5 | 2020 | 16367 | 0.060 |
Why?
|
| Muscle, Smooth | 1 | 2009 | 934 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 2 | 2021 | 9274 | 0.060 |
Why?
|
| Cell Nucleus | 3 | 2023 | 2969 | 0.060 |
Why?
|
| Dinucleotide Repeats | 1 | 2004 | 30 | 0.060 |
Why?
|
| Dietary Fats | 1 | 2012 | 2016 | 0.060 |
Why?
|
| Testicular Hormones | 1 | 2004 | 188 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 1790 | 0.060 |
Why?
|
| Cloning, Molecular | 2 | 2004 | 4320 | 0.060 |
Why?
|
| Cyclin D1 | 1 | 2006 | 463 | 0.060 |
Why?
|
| Zebrafish Proteins | 1 | 2010 | 1005 | 0.060 |
Why?
|
| HeLa Cells | 1 | 2010 | 3130 | 0.060 |
Why?
|
| DNA-Binding Proteins | 6 | 2010 | 9647 | 0.060 |
Why?
|
| Genotype | 3 | 2015 | 12952 | 0.060 |
Why?
|
| Prognosis | 8 | 2012 | 29060 | 0.060 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2008 | 370 | 0.060 |
Why?
|
| Neurogenesis | 1 | 2010 | 838 | 0.060 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2004 | 107 | 0.060 |
Why?
|
| Life Style | 1 | 2015 | 3835 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 1862 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2002 | 644 | 0.060 |
Why?
|
| Databases, Genetic | 1 | 2011 | 1783 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2010 | 1335 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2021 | 1656 | 0.060 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2007 | 644 | 0.060 |
Why?
|
| Animals, Congenic | 1 | 2003 | 27 | 0.060 |
Why?
|
| Rad51 Recombinase | 1 | 2024 | 189 | 0.060 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2013 | 2038 | 0.060 |
Why?
|
| Enzyme Inhibitors | 4 | 2002 | 3799 | 0.060 |
Why?
|
| Hydrogen Peroxide | 2 | 2023 | 730 | 0.060 |
Why?
|
| Restriction Mapping | 1 | 2004 | 878 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2010 | 3001 | 0.060 |
Why?
|
| Receptors, Estrogen | 2 | 2009 | 2190 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 1888 | 0.060 |
Why?
|
| Carcinoma, Papillary | 1 | 2008 | 783 | 0.050 |
Why?
|
| Spain | 1 | 2004 | 465 | 0.050 |
Why?
|
| Aged | 10 | 2017 | 163288 | 0.050 |
Why?
|
| Embryo Implantation | 1 | 2004 | 272 | 0.050 |
Why?
|
| Base Sequence | 4 | 2005 | 12797 | 0.050 |
Why?
|
| Fallopian Tubes | 1 | 2023 | 182 | 0.050 |
Why?
|
| Caspase 8 | 1 | 2003 | 195 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2005 | 690 | 0.050 |
Why?
|
| Giant Cell Arteritis | 1 | 2006 | 292 | 0.050 |
Why?
|
| Wound Healing | 1 | 2013 | 2785 | 0.050 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2022 | 123 | 0.050 |
Why?
|
| Glutamates | 1 | 2023 | 398 | 0.050 |
Why?
|
| Adult | 10 | 2019 | 214052 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2015 | 5096 | 0.050 |
Why?
|
| Recombinant Proteins | 3 | 2019 | 6621 | 0.050 |
Why?
|
| Rabbits | 3 | 2013 | 4894 | 0.050 |
Why?
|
| Rats | 4 | 2015 | 24252 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 2088 | 0.050 |
Why?
|
| Proline | 1 | 2023 | 458 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2011 | 10252 | 0.050 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2023 | 338 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2010 | 3480 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2008 | 1640 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2002 | 682 | 0.050 |
Why?
|
| Aged, 80 and over | 7 | 2017 | 57776 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2017 | 17446 | 0.050 |
Why?
|
| Ovulation | 1 | 2002 | 189 | 0.050 |
Why?
|
| Cohort Studies | 6 | 2020 | 40559 | 0.050 |
Why?
|
| Colorectal Neoplasms | 2 | 2013 | 6773 | 0.050 |
Why?
|
| Gene Frequency | 2 | 2006 | 3587 | 0.050 |
Why?
|
| Administration, Oral | 3 | 2013 | 3914 | 0.050 |
Why?
|
| Cell Line | 4 | 2019 | 16000 | 0.050 |
Why?
|
| Protein Transport | 2 | 2019 | 1988 | 0.050 |
Why?
|
| STAT3 Transcription Factor | 2 | 2004 | 874 | 0.050 |
Why?
|
| Neovascularization, Physiologic | 1 | 2008 | 1351 | 0.050 |
Why?
|
| Gonanes | 1 | 2000 | 2 | 0.050 |
Why?
|
| Aminoglutethimide | 1 | 2000 | 15 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2004 | 1185 | 0.050 |
Why?
|
| Diet | 2 | 2015 | 7937 | 0.050 |
Why?
|
| Glutathione | 1 | 2003 | 590 | 0.050 |
Why?
|
| DNA Damage | 1 | 2010 | 2432 | 0.050 |
Why?
|
| STAT1 Transcription Factor | 1 | 2001 | 320 | 0.040 |
Why?
|
| Pregnancy Proteins | 1 | 2001 | 229 | 0.040 |
Why?
|
| Middle Aged | 11 | 2017 | 213390 | 0.040 |
Why?
|
| Hormone Antagonists | 1 | 2000 | 108 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 4185 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 1801 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2002 | 697 | 0.040 |
Why?
|
| Receptors, Endothelin | 1 | 1999 | 58 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 3617 | 0.040 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2024 | 594 | 0.040 |
Why?
|
| Radioimmunoassay | 1 | 2000 | 919 | 0.040 |
Why?
|
| Genes, Synthetic | 1 | 2019 | 90 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 1701 | 0.040 |
Why?
|
| Mifepristone | 1 | 2000 | 150 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 2 | 2014 | 1799 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2004 | 18111 | 0.040 |
Why?
|
| NF-kappa B | 2 | 2013 | 2499 | 0.040 |
Why?
|
| Aromatase | 1 | 2019 | 147 | 0.040 |
Why?
|
| Peptide Hydrolases | 1 | 2022 | 634 | 0.040 |
Why?
|
| Prevalence | 1 | 2015 | 15221 | 0.040 |
Why?
|
| Fetal Blood | 1 | 2005 | 1318 | 0.040 |
Why?
|
| Quinazolines | 2 | 2016 | 1356 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 1999 | 475 | 0.040 |
Why?
|
| Ascites | 1 | 2020 | 344 | 0.040 |
Why?
|
| Feedback | 1 | 2022 | 795 | 0.040 |
Why?
|
| Aging | 2 | 2019 | 8664 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2019 | 365 | 0.040 |
Why?
|
| Autoradiography | 1 | 1999 | 745 | 0.040 |
Why?
|
| Random Allocation | 2 | 2013 | 2428 | 0.040 |
Why?
|
| RNA Interference | 2 | 2019 | 2890 | 0.040 |
Why?
|
| Matched-Pair Analysis | 1 | 2018 | 288 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2022 | 4479 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2010 | 12356 | 0.040 |
Why?
|
| Antigens, CD34 | 1 | 2019 | 659 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2003 | 2184 | 0.040 |
Why?
|
| Ligands | 2 | 2020 | 3282 | 0.040 |
Why?
|
| Receptors, OSM-LIF | 2 | 2008 | 15 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2001 | 542 | 0.040 |
Why?
|
| Leukemia Inhibitory Factor | 2 | 2008 | 61 | 0.040 |
Why?
|
| Spleen | 1 | 2003 | 2362 | 0.040 |
Why?
|
| Young Adult | 2 | 2014 | 56429 | 0.040 |
Why?
|
| Time Factors | 2 | 2020 | 40075 | 0.040 |
Why?
|
| Concanavalin A | 2 | 2008 | 191 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2009 | 2987 | 0.040 |
Why?
|
| Cyclooxygenase 2 | 2 | 2014 | 612 | 0.030 |
Why?
|
| Heterochromatin | 1 | 2019 | 296 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2007 | 4805 | 0.030 |
Why?
|
| E2F2 Transcription Factor | 1 | 2015 | 38 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 4561 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 808 | 0.030 |
Why?
|
| Caspase 1 | 1 | 1997 | 224 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2004 | 1788 | 0.030 |
Why?
|
| Epithelium | 1 | 2020 | 1679 | 0.030 |
Why?
|
| Genes, cdc | 1 | 2015 | 116 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 1997 | 295 | 0.030 |
Why?
|
| Benzoxazoles | 1 | 2016 | 77 | 0.030 |
Why?
|
| Superovulation | 1 | 1995 | 11 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 5856 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 10943 | 0.030 |
Why?
|
| bcl-X Protein | 1 | 1997 | 411 | 0.030 |
Why?
|
| Epitopes | 1 | 2022 | 2571 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2000 | 1060 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2003 | 2617 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2016 | 399 | 0.030 |
Why?
|
| Retinoblastoma Protein | 1 | 2019 | 705 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1995 | 212 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2002 | 1403 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1038 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2017 | 351 | 0.030 |
Why?
|
| Pregnancy Outcome | 2 | 2018 | 2795 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2013 | 1692 | 0.030 |
Why?
|
| Cycloheximide | 1 | 1995 | 347 | 0.030 |
Why?
|
| Pregnancy Rate | 1 | 2018 | 643 | 0.030 |
Why?
|
| Peritoneal Neoplasms | 1 | 2020 | 665 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2005 | 4162 | 0.030 |
Why?
|
| Neoplasms | 1 | 2023 | 21696 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2019 | 1536 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2019 | 1619 | 0.030 |
Why?
|
| Genes, myc | 1 | 2015 | 399 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2010 | 7721 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2007 | 3646 | 0.030 |
Why?
|
| Genes, p53 | 1 | 1997 | 755 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2013 | 15297 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 1997 | 563 | 0.030 |
Why?
|
| Live Birth | 1 | 2018 | 512 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2009 | 4251 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2015 | 302 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2010 | 21748 | 0.030 |
Why?
|
| Antibodies | 1 | 2022 | 2460 | 0.030 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2013 | 113 | 0.030 |
Why?
|
| Culture Media | 1 | 2015 | 909 | 0.030 |
Why?
|
| Breeding | 1 | 2012 | 51 | 0.030 |
Why?
|
| Litter Size | 1 | 2012 | 54 | 0.030 |
Why?
|
| Promegestone | 1 | 2012 | 9 | 0.030 |
Why?
|
| Chorionic Gonadotropin | 1 | 1995 | 476 | 0.030 |
Why?
|
| Phosphorylation | 4 | 2010 | 8436 | 0.030 |
Why?
|
| Up-Regulation | 3 | 2009 | 4222 | 0.030 |
Why?
|
| Age Factors | 2 | 2007 | 18373 | 0.030 |
Why?
|
| Cullin Proteins | 1 | 2013 | 181 | 0.030 |
Why?
|
| Survival Rate | 2 | 2020 | 12788 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1995 | 2255 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 15520 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2016 | 1794 | 0.030 |
Why?
|
| Soybean Oil | 1 | 2012 | 133 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2003 | 3084 | 0.030 |
Why?
|
| Plant Oils | 1 | 2012 | 202 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 2216 | 0.030 |
Why?
|
| Massachusetts | 2 | 2018 | 8662 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 2133 | 0.030 |
Why?
|
| Cell Division | 1 | 2019 | 4569 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2019 | 2513 | 0.020 |
Why?
|
| Male | 12 | 2013 | 350115 | 0.020 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2012 | 142 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 2007 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2013 | 580 | 0.020 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2012 | 227 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2013 | 675 | 0.020 |
Why?
|
| Infertility | 1 | 2018 | 655 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2011 | 2949 | 0.020 |
Why?
|
| New Hampshire | 1 | 2010 | 172 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2010 | 112 | 0.020 |
Why?
|
| Proteomics | 1 | 2023 | 3638 | 0.020 |
Why?
|
| Mitochondria | 1 | 2023 | 3514 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2013 | 987 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2019 | 2073 | 0.020 |
Why?
|
| Phase Transition | 1 | 2009 | 74 | 0.020 |
Why?
|
| Propylene Glycols | 1 | 2009 | 92 | 0.020 |
Why?
|
| Trehalose | 1 | 2009 | 88 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2009 | 356 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 2013 | 895 | 0.020 |
Why?
|
| Mitosis | 1 | 2014 | 1208 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2011 | 376 | 0.020 |
Why?
|
| Placebos | 1 | 2013 | 1676 | 0.020 |
Why?
|
| Fertilization | 1 | 2009 | 196 | 0.020 |
Why?
|
| Nitrogen | 1 | 2009 | 344 | 0.020 |
Why?
|
| Proteins | 1 | 2023 | 6100 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2013 | 1686 | 0.020 |
Why?
|
| COS Cells | 1 | 2010 | 1161 | 0.020 |
Why?
|
| Plant Lectins | 1 | 2008 | 104 | 0.020 |
Why?
|
| Uterine Diseases | 1 | 2009 | 135 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2010 | 563 | 0.020 |
Why?
|
| Egtazic Acid | 1 | 2007 | 173 | 0.020 |
Why?
|
| Transfection | 1 | 2016 | 5895 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2010 | 504 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2010 | 390 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 1120 | 0.020 |
Why?
|
| Chemoprevention | 1 | 2009 | 319 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2009 | 1828 | 0.020 |
Why?
|
| Remission Induction | 1 | 2012 | 2385 | 0.020 |
Why?
|
| Adolescent | 1 | 2014 | 85779 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2009 | 520 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2018 | 53290 | 0.020 |
Why?
|
| Embryo Transfer | 1 | 2009 | 510 | 0.020 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2007 | 335 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2008 | 661 | 0.020 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2020 | 3143 | 0.020 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2009 | 387 | 0.020 |
Why?
|
| HLA-B Antigens | 1 | 2006 | 354 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2010 | 1227 | 0.020 |
Why?
|
| Europe | 1 | 2012 | 3338 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 2007 | 869 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 625 | 0.020 |
Why?
|
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2004 | 16 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2009 | 711 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 2006 | 645 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2007 | 894 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2008 | 767 | 0.020 |
Why?
|
| Integrin beta3 | 1 | 2004 | 122 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2016 | 2943 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 2020 | 4262 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 2009 | 1182 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2007 | 1472 | 0.010 |
Why?
|
| Receptors, Peptide | 1 | 2004 | 272 | 0.010 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2004 | 314 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2012 | 4740 | 0.010 |
Why?
|
| Endothelin-1 | 1 | 2005 | 314 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2012 | 1912 | 0.010 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 972 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2009 | 1783 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2018 | 63107 | 0.010 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2004 | 402 | 0.010 |
Why?
|
| Hysterectomy | 1 | 2008 | 927 | 0.010 |
Why?
|
| Carbocyanines | 1 | 2002 | 174 | 0.010 |
Why?
|
| Lymph Node Excision | 1 | 2008 | 1262 | 0.010 |
Why?
|
| Monocytes | 1 | 2012 | 2596 | 0.010 |
Why?
|
| Endothelium | 1 | 2005 | 778 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 3611 | 0.010 |
Why?
|
| CHO Cells | 1 | 2004 | 1409 | 0.010 |
Why?
|
| Precancerous Conditions | 1 | 2009 | 975 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2008 | 77460 | 0.010 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2003 | 282 | 0.010 |
Why?
|
| Caspase 7 | 1 | 2001 | 56 | 0.010 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 2001 | 40 | 0.010 |
Why?
|
| Binding Sites | 1 | 2010 | 6111 | 0.010 |
Why?
|
| Tumor Microenvironment | 1 | 2013 | 3590 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2010 | 2251 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5445 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 2012 | 1534 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2005 | 1341 | 0.010 |
Why?
|
| Cricetinae | 1 | 2004 | 2475 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 4666 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2001 | 554 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2011 | 3493 | 0.010 |
Why?
|
| Homozygote | 1 | 2005 | 1787 | 0.010 |
Why?
|
| Recurrence | 1 | 2012 | 8340 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2001 | 203 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2004 | 1263 | 0.010 |
Why?
|
| Chromones | 1 | 2000 | 154 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2001 | 286 | 0.010 |
Why?
|
| Heart | 1 | 2013 | 4464 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2006 | 1366 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2001 | 329 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 6171 | 0.010 |
Why?
|
| Receptor, Endothelin A | 1 | 1999 | 58 | 0.010 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2003 | 507 | 0.010 |
Why?
|
| Macrophages | 1 | 2014 | 5660 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2916 | 0.010 |
Why?
|
| Chemokines | 1 | 2003 | 970 | 0.010 |
Why?
|
| Lipoproteins, LDL | 1 | 2002 | 640 | 0.010 |
Why?
|
| Renin-Angiotensin System | 1 | 2003 | 758 | 0.010 |
Why?
|
| DNA Primers | 1 | 2003 | 2891 | 0.010 |
Why?
|
| Heterozygote | 1 | 2005 | 2804 | 0.010 |
Why?
|
| Androstadienes | 1 | 2000 | 345 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2001 | 575 | 0.010 |
Why?
|
| Flavonoids | 1 | 2001 | 443 | 0.010 |
Why?
|
| Liver | 1 | 2013 | 7475 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2005 | 1837 | 0.010 |
Why?
|
| Genome, Human | 1 | 2011 | 4420 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2008 | 6896 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2018 | 25628 | 0.010 |
Why?
|
| Comorbidity | 1 | 2012 | 10388 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 12244 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2014 | 10183 | 0.010 |
Why?
|
| Disease Progression | 1 | 2013 | 13286 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2001 | 1728 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2001 | 2726 | 0.010 |
Why?
|
| Logistic Models | 1 | 2010 | 13409 | 0.010 |
Why?
|
| Protein Binding | 1 | 2007 | 9384 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 1917 | 0.010 |
Why?
|
| Inflammation | 1 | 2014 | 10637 | 0.010 |
Why?
|
| Oxygen | 1 | 2005 | 4189 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 19905 | 0.010 |
Why?
|
| Kinetics | 1 | 2000 | 6476 | 0.010 |
Why?
|
| Estradiol | 1 | 1999 | 2020 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 1995 | 957 | 0.010 |
Why?
|
| Incidence | 1 | 2009 | 20952 | 0.010 |
Why?
|
| Swine | 1 | 2000 | 5918 | 0.010 |
Why?
|
| Insulin | 1 | 1999 | 6582 | 0.000 |
Why?
|
| Risk Factors | 1 | 2011 | 72296 | 0.000 |
Why?
|
| Body Mass Index | 1 | 2001 | 12721 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1995 | 13814 | 0.000 |
Why?
|